NYC, Corporate Partners Launch $100M Life Sciences Investment Fund | GenomeWeb

NEW YORK (GenomeWeb News) – The New York Economic Development Corporation said today it has launched an initiative that will inject $100 million into life sciences startup companies located in the city through a mix of money from city government, life sciences companies, and venture capital partners.

The City of New York Early-Stage Life Sciences Funding Initiative will seek to invest in 15 to 20 early-stage research and development companies by 2020, according to the NYCEDC.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Startup companies are taking on personalized medicine, CNET reports.

Bruce Booth writes at Life Sci VC that biotech clusters like Boston and San Francisco are getting even more consolidated.

The Verge speaks with Mark and Scott Kelly, who are the subjects of NASA's Twin Study.

In Genome Biology this week: genes linked to Hirschsprung disease, structural variant patterns in autism, and more.